Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib.
Bex
Axel
A
Van der Veldt
Astrid A M
AA
Blank
Christian
C
Meijerink
Martijn R
MR
Boven
Epie
E
Haanen
John B A G
JB
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000556:secondary; D002292:Carcinoma, Renal Cell / Q000150:complications* / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D018450:Disease Progression; D017809:Fatal Outcome; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D008113:Liver Neoplasms / Q000556:secondary; D008875:Middle Aged; D020360:Neoadjuvant Therapy / Q000379:methods*; D009392:Nephrectomy; D011758:Pyrroles / Q000627:therapeutic use*; D000077210:Sunitinib; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D014682:Vena Cava, Inferior / Q000000981:diagnostic imaging; D020246:Venous Thrombosis / Q000000981:diagnostic imaging / Q000209:etiology*
D020533:Angiogenesis Inhibitors; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib